Search results
Results from the WOW.Com Content Network
The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race is a non-fiction book authored by American historian and journalist Walter Isaacson. Published in March 2021 by Simon & Schuster , it is a biography of Jennifer Doudna , the winner of the 2020 Nobel Prize in Chemistry for her work on the CRISPR system of gene ...
[2] [3] [4] The Wall Street Journal's reviewer said the book has compiled "perhaps the most comprehensive case for the lab-leak theory currently available". [5] Columnist Michael Hiltzik wrote in the Los Angeles Times that the authors "place[d] a conspiracy theory between hardcovers to masquerade as sober scientific inquiry."
He co-developed Multiplex Automated Genome Engineering (MAGE) and optimized CRISPR/Cas9, discovered by Jennifer Doudna and Emmanuelle Charpentier for engineering a variety of genomes ranging from yeast to human. [62] His laboratory's use of CRISPR in human induced pluripotent stem cells (hiPS) is the latest contender for precise gene therapy. [64]
Where to shop today's best deals: Kate Spade, Amazon, Walmart and more. AOL. The best under-$50 clothing items to buy at Amazon right now. See all deals. In Other News. Entertainment.
Unnatural Selection (or stylized as, "unnatural selection") is a 2019 American documentary television series.It presents an overview of genetic engineering, particularly the DNA-editing technology of CRISPR, from the perspective of scientists, corporations and biohackers working from their home.
The sports world had an unexpected loss this week, with football analyst Kirk Herbstreit announcing Thursday that his beloved dog Ben has died.
"The increased prevalence of outdoor activities and gatherings in a post-COVID-19 world will further expose large numbers of people to potential vulnerabilities within security that place them at ...
The CRISPR treatment for LCA10 (the most common variant of Leber congenital amaurosis which is the leading cause of inherited childhood blindness) modifies the patient's defective photoreceptor gene. In March 2020, the first patient volunteer in this US-based study, sponsored by Editas Medicine , was given a low-dose of the treatment to test ...